Cellceutix Corp (OTCMKTS:CTIX) continues to see general decline since the pop it saw in November to highs near $2 a share after the Company announced the...
Cellceutix Corp (OTCMKTS:CTIX) is one penny stock that has got everyone’s attention sitting on drugs in development that could potentially turn the multi-billion dollar drug-resistant cancers...
Cellceutix Corp (OTCMKTS:CTIX) continues to trade on the comeback trail since hitting a recent low of $1.32 after a SA hit piece came out titled ”Cellceutix:...
Cellceutix Corp (OTCMKTS:CTIX) recently traded as low as $1.32 after a SA hit piece came out titled ”Cellceutix: Empty Office, Unviable ‘Science’, Misleading Disclosures, 96% Downside”...
Cellceutix Corp (OTCMKTS:CTIX) is making a big move up on accelerating volume on some big news from the Company. On July 20 the Company announced the...
Cellceutix Corp (OTCMKTS:CTIX) is trading well just over its $2.50 base. The stock is still in consolidation mode after the run up to highs of $4.93...
